MP Materials Corp. — Q2 2023 Form 10-Q
Reporting period: Quarter and six months ended June 30, 2023. Unaudited results. MP Materials operates Mountain Pass, a rare-earth mine and processing facility, and is developing separated-material and downstream magnet operations.
Financial performance
| Metric | Q2 2023 | Q2 2022 | Six months 2023 | Six months 2022 |
|---|---|---|---|---|
| Revenue | $64.0 million | $143.6 million | $159.7 million | $309.8 million |
| Operating income | $0.5 million | $95.8 million | $33.4 million | $210.8 million |
| Net income | $7.4 million | $73.3 million | $44.8 million | $158.8 million |
| Diluted EPS | $0.04 | $0.38 | $0.24 | $0.83 |
| Adjusted EBITDA (non-GAAP) | $27.0 million | $110.0 million | $85.7 million | $242.2 million |
Q2 revenue fell 55% year over year, principally as realized price per REO metric ton declined 55% to $6,231; sales volume rose 3%. For the first half, revenue declined 48%, reflecting a 44% lower realized price and 6% lower sales volume. Q2 operating margin was approximately 0.8%, versus 66.7% a year earlier; net income included $13.8 million of other income, principally investment income. Higher start-up costs, depreciation, and demolition costs also weighed on operating results.
Q2 REO production increased 5% to 10,863 metric tons; sales volume increased 3% to 10,271 metric tons. Production cost per REO metric ton rose 11% to $1,938. For the first half, production increased 2% to 21,534 metric tons, while sales declined 6% to 20,486 metric tons and production cost per ton increased 18% to $1,958.
Cash flow, liquidity, and debt
- At June 30, cash, cash equivalents, and short-term investments totaled $1.128 billion, compared with $1.182 billion at year-end 2022. Current assets were $1.224 billion and current liabilities $75.8 million.
- First-half operating cash flow was $65.5 million, down from $219.9 million. Capital expenditures were $130.2 million; company-defined free cash flow (non-GAAP) was negative $64.8 million.
- Investing activities provided $728.1 million, largely reflecting short-term investment maturities and sales; this was not operating cash generation.
- Long-term debt was $690 million principal amount of 0.25% convertible notes due April 2026, with a $680.2 million net carrying value. Equipment notes totaled $5.9 million. The notes’ conversion price was initially $44.28 per share.
Outlook, developments, and risks
- Management expected approximately $300 million of 2023 capital spending, covering Stage II, heavy rare earth processing, Fort Worth magnet operations, and other growth and infrastructure work. It believes available cash can fund near-term plans but cautions that costs or schedules may increase and additional financing may be needed if resources prove inadequate.
- Stage II commissioning continued during Q2. Management expected REO sales volume to be significantly below production in the second half of 2023 as material is retained for separation. GM’s gradual production ramp was expected to begin in late 2023, starting with alloy; this is an expectation, not a reported result.
- Shenghe, a related party, accounted for more than 90% of product sales. Concentrate pricing depends in part on realized market prices in China, creating customer, market-price, currency, and geopolitical exposure.
- Other notable items: Q2 demolition costs were $2.2 million; first-half demolition costs were $4.7 million. The company reported no material pending or threatened litigation and no material changes to its previously disclosed risk factors. Disclosure controls were reported effective.
Most important facts for investors to verify
- Whether Stage II commissioning achieves planned production, product quality, and cost targets, and how much production is withheld from concentrate sales.
- Whether rare-earth prices and realized prices recover or continue to pressure revenue and margins.
- Customer concentration and the terms, duration, and practical operation of the Shenghe offtake arrangement.
- Actual versus expected capital spending, project timing, and funding needs for Stage II, the HREE facility, and Fort Worth.
- How the company’s cash balance, operating cash generation, and convertible-note dilution exposure evolve.